- Home
- ARTNA vs RCKT Comparison
ARTNA vs RCKT Comparison
Compare ARTNA & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARTNA
- RCKT
- Stock Information
- Founded
- ARTNA 1905
- RCKT 1999
- Country
- ARTNA United States
- RCKT United States
- Employees
- ARTNA N/A
- RCKT N/A
- Industry
- ARTNA Water Supply
- RCKT Biotechnology: Pharmaceutical Preparations
- Sector
- ARTNA Utilities
- RCKT Health Care
- Exchange
- ARTNA Nasdaq
- RCKT Nasdaq
- Market Cap
- ARTNA 343.5M
- RCKT 328.6M
- IPO Year
- ARTNA 1996
- RCKT N/A
- Fundamental
- Price
- ARTNA $33.15
- RCKT $3.28
- Analyst Decision
- ARTNA
- RCKT Buy
- Analyst Count
- ARTNA 0
- RCKT 13
- Target Price
- ARTNA N/A
- RCKT $12.96
- AVG Volume (30 Days)
- ARTNA 28.6K
- RCKT 6.0M
- Earning Date
- ARTNA 08-04-2025
- RCKT 08-07-2025
- Dividend Yield
- ARTNA 3.71%
- RCKT N/A
- EPS Growth
- ARTNA 22.07
- RCKT N/A
- EPS
- ARTNA 2.17
- RCKT N/A
- Revenue
- ARTNA $110,427,000.00
- RCKT N/A
- Revenue This Year
- ARTNA $6.86
- RCKT N/A
- Revenue Next Year
- ARTNA $4.46
- RCKT $108.43
- P/E Ratio
- ARTNA $15.28
- RCKT N/A
- Revenue Growth
- ARTNA 7.13
- RCKT N/A
- 52 Week Low
- ARTNA $29.45
- RCKT $2.19
- 52 Week High
- ARTNA $38.94
- RCKT $22.01
- Technical
- Relative Strength Index (RSI)
- ARTNA 48.19
- RCKT 51.17
- Support Level
- ARTNA $33.00
- RCKT $2.88
- Resistance Level
- ARTNA $34.28
- RCKT $3.74
- Average True Range (ATR)
- ARTNA 0.66
- RCKT 0.27
- MACD
- ARTNA 0.01
- RCKT 0.02
- Stochastic Oscillator
- ARTNA 36.90
- RCKT 35.43
About ARTNA Artesian Resources Corporation
Artesian Resources Corp operates as a holding company with a focus on water distribution and wastewater services. Its regulated utility segment includes subsidiaries providing water and wastewater services in Delaware, Maryland, and Pennsylvania. Water distribution spans residential, commercial, industrial, and municipal sectors, while wastewater services are offered in Sussex County, Delaware. The company also engages in non-utility businesses, offering service line protection plans, engineering services, and contract operations for water and wastewater systems. The regulated utility segment constitutes the portion of the company's operations, subject to regulations by Delaware, Maryland, and Pennsylvania.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.